Why AlignerService Does Not Support In-House Clear Aligner Production

Updated 2025

A conscious clinical decision – not a technological limitation

At AlignerService, we are often asked why we do not support in-house production of clear aligners or 3D-printed aligner workflows.

The answer is simple and deliberate:
We prioritise clinical precision, predictability, and patient safety over theoretical cost savings.

This is not a marketing position.
It is a clinical one.

Closed, calibrated workflows outperform open systems

We work exclusively with the world’s leading clear aligner manufacturers:
Invisalign, ClearCorrect, SureSmile, Spark, Angel Aligner, TrioClear, and Clarity.

These systems are built on closed, calibrated, and validated digital workflows, where:

Data loss is minimal
Each step is controlled and standardised
Manufacturing tolerances are known and predictable

The result is simple:
Higher precision, greater predictability, and fewer refinements.

The problem with in-house aligner production

Open, in-house aligner workflows introduce multiple uncontrolled variables, including:

File conversions and data degradation
Printer calibration variability
Material inconsistencies
Post-processing and curing errors

We have tested these systems ourselves.

Yes - they can work for very simple cases.
But as soon as case complexity increases, precision drops.

What follows is predictable:

Increased need for refinements
More chair time
More micromanagement
More clinical compromises

Any money saved on production is typically lost again through additional treatment time and reduced predictability.

That is not efficiency.
That is hidden cost.

Clinical compromises we will not stand behind

At AlignerService, we only support workflows we can defend clinically.

In-house aligner production often forces dentists to choose between:

Accepting reduced precision
Limiting case complexity
Or compensating with excessive refinements

We are not willing to support workflows that shift risk and inefficiency onto the clinician and the patient.

Patient safety matters

There are still unresolved concerns regarding:

Material stability
Potential toxicity in 3D-printed aligners
Residual monomers

While the technology shows promise, current printed aligner materials and production reliability are not at a level we consider acceptable for routine clinical use.

Patient safety is not an area for experimentation.

Our role is clinical - not technical

AlignerService focuses exclusively on:

Diagnostics
Treatment planning
Clinical decision-making
Ongoing clinical support

We deliberately stay independent of:

Software development
Printers and hardware
Materials and production methods

This independence allows us to give unbiased, clinically grounded advice - without conflicts of interest.

The AlignerService position

We help dentists deliver:

Predictable treatments
Fewer refinements
Lower chair time
Scalable aligner workflows

To achieve that, we choose validated aligner systems with proven precision.

That is why we do not support in-house clear aligner production.

Not because we cannot.
But because we will not compromise.